查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948161

全球類器官市場：機會與策略展望（至2034年）

Organoids Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 393 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球類器官市場預計到2024年將達到約6.9006億美元，自2019年以來年複合成長率（CAGR）為21.03%。預計該市場將從2024年的6.9006億美元成長到2029年的16.0546億美元，年複合成長率為18.40%。 2029年之後，預計該市場將繼續以17.71%的年複合成長率成長，到2034年達到36.2743億美元。

類器官是由幹細胞培養而成的3D（3D）微型自組織組織結構，能夠模擬真實器官的關鍵結構與功能特徵。與傳統的2D（2D）細胞培養相比，類器官具有更高的生理相關性，因為它們能夠模擬複雜的細胞間相互作用、組織結構和生物學行為。類器官的主要目的是為疾病研究、藥物研發、毒性測試和個人化醫療提供逼真的生物模型。

類器官市場是指機構、自營商或夥伴關係銷售類器官產品，這些產品是試管內培養的器官的微型化、簡化版3D模型。這些結構源自於幹細胞或組織細胞，展現出逼真的微觀解剖結構，並具有自我更新和分化的能力。

對製藥和生物技術公司的投資增加

過去一段時間，對製藥和生物技術公司投資的增加推動了類器官市場的成長。生物技術領域資金籌措的增加使各機構能夠將更多資金投入到類器官等創新平台，因為他們認知到這些平台在簡化藥物研發流程和減少代價高昂的失敗方面具有巨大潛力。更容易獲得資金籌措也鼓勵企業擴大實驗室能力、取得專業的幹細胞技術，並開發用於篩檢和檢驗的先進類器官模型。例如，根據美國資訊服務公司Fierce Biotech在2025年9月發布的一份報告，美國國立衛生研究院（NIH）正在透過授予一項價值8700萬美元的合約來建立一個標準化類器官建模（SOM）中心，從而進一步推進其最大限度減少藥物測試中動物使用的目標。因此，對製藥和生物技術公司投資的增加推動了類器官市場的成長。

重點研究血管化和功能成熟的類器官模型

類器官市場的企業正致力於研發血管化且功能成熟的類器官模型，以更真實地再現人體組織的結構和生理反應。這將推動疾病建模、再生醫學和藥物測試等領域的發展。例如，2025年6月，美國辛辛那提兒童醫院醫學中心成功開發出能夠自我形成器官特異性血管的肝臟類器官，這標誌著組織工程領域的重大突破。研究人員利用多層凝膠技術，誘導肝竇血管前驅細胞遷移和分支，並與周圍的肝細胞融合，最終形成功能性的肝竇血管系統。這些血管化的類器官能夠產生關鍵的凝血因子，包括VIII因子，並能抑制血友病模型小鼠的出血。這種方法有望克服類器官長期存在的難題——缺乏內部血管系統——並為可移植肝組織的開發、先進的疾病建模以及凝血障礙的新治療方法鋪平道路。

全球類器官市場集中度較高，主要由幾家大型企業主導。截至2024年，排名前十的市場競爭對手佔據了33.53%的市場。

目錄

第1章執行摘要

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章 市場特徵

  • 一般市場定義
  • 概述
  • 類器官市場定義與細分
  • 按產品分類的市場細分
    • 肝臟類器官
    • 結腸類器官
    • 腸道類器官
    • 其他類器官
  • 市場區隔：依來源
    • 多功能細胞
    • 器官特異性成體幹細胞
  • 市場區隔：按應用
    • 發育生物學
    • 感染疾病的發病機制
    • 再生醫學
    • 藥物毒性和療效測試
    • 藥物發現與個人化醫療
    • 其他用途
  • 市場區隔：依最終用戶分類
    • 醫院和診斷中心
    • 生物技術和製藥公司
    • 其他最終用戶

第7章：主要市場趨勢

  • 重點研究血管化和功能成熟的類器官模型
  • 開發可擴展、長壽命的功能性類器官模型
  • 創新和拓展用於生物治療研究的類器官解決方案
  • 生命科學研究在專業化3D細胞模型生產上取得進展
  • 開發基於心臟類器官的試劑盒以改善心臟安全性測試

8. 類器官生長分析與策略分析框架

  • 類器官的PESTEL分析（政治、社會、技術、環境與法律因素）
    • 政治因素
    • 經濟
    • 社會的
    • 技術的
    • 環境因素
    • 合法的
  • 終端用戶（B2B）市場分析
    • 醫院和診斷中心
    • 生物技術和製藥公司
    • 其他最終用戶
  • 類器官市場：成長率分析
  • 2019-2024年全球市場成長表現
    • 2019-2024年市場促進因素
    • 2019-2024年市場限制因素
  • 全球市場成長預測，2024-2029年，2034年預測
  • 預期成長要素/促進因素
    • 定量成長要素
    • 促進要素
    • 抑制因素
  • 類器官總潛在市場（TAM）
    • TAM比較分析

第9章 類器官市場：細分

  • 全球類器官市場：依產品、效能及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球類器官市場：依來源、表現及預測（2019-2024年、2029年預測、2034年預測）
  • 全球類器官市場：依應用、效能和預測分類，2019-2024年、2029年預測、2034年預測
  • 全球類器官市場：依最終使用者、效能和預測分類，2019-2024年、2029年預測、2034年預測
  • 全球類器官市場：依類型（肝臟類器官）細分、表現及預測，2019-2024年、2029年預測、2034年預測
  • 全球類器官市場：細分：結直腸類器官，按類型、表現和預測（2019-2024 年、2029 年預測、2034 年預測）
  • 全球類器官市場：細分：腸道類器官，按類型、表現和預測（2019-2024年、2029年預測、2034年預測）
  • 全球類器官市場：細分：其他類器官，按類型、表現和預測（2019-2024 年、2029 年預測、2034 年預測）

第10章：類器官市場：區域與國家分析

  • 類器官市場：區域表現及預測，2019-2024年、2029年預測、2034年預測
  • 類器官市場：國家、表現及預測，2019-2024年、2029年預測、2034年預測

第11章 亞太市場

第12章 西歐市場

第13章 東歐市場

第14章 北美市場

第15章：南美市場

第16章 中東市場

第17章：非洲市場

第18章：競爭格局與公司概況

  • 公司簡介
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA（Hubrecht Organoid Technology（HUB））
  • STEMCELL Technologies Inc
  • Danaher Corporation（Cellesce Ltd）

第19章：其他領先和創新企業

  • Sartorius AG
  • Charles River Laboratories International, Inc.
  • Bio-Techne Corp.
  • Greiner Bio-One International GmbH
  • ACROBiosystems Inc.
  • Crown Bioscience（OcellO BV）
  • InSphero AG
  • ATCC（American Type Culture Collection）
  • Axol Bioscience Ltd.
  • Newcells Biotech Ltd.
  • Pandorum Technologies Pvt. Ltd.
  • 3Dnamics Inc.
  • 3D Biotek LLC
  • AMS Biotechnology（Europe）Limited
  • CelVivo ApS

第20章：競爭標竿分析

第21章 競爭格局分析

第22章 重大併購

  • Merck Group Acquired HUB Organoids Holding BV
  • Bruker Corporation Acquired Acquifer Imaging
  • Molecular Devices Acquired Cellesce

第23章：類器官研究的最新趨勢

  • 標準化類器官平台革新人工智慧驅動的藥物測試
  • 光學石墨烯刺激技術革新腦類器官與神經生物混合研究
  • 3D類器官平台革新精準醫療藥物篩檢

第24章：機遇與策略

  • 2029年類器官市場－最具發展機會的國家
  • 2029年類器官市場－最具新興機會的細分市場
  • 類器官市場成長策略至2029年
    • 基於市場趨勢的策略
    • 競爭對手策略

第25章 類器官市場：結論與建議

  • 結論
  • 建議

第26章附錄

簡介目錄
Product Code: HS5MORGA01_O25Q4

Organoids are three-dimensional (3D) miniaturized and self-organizing tissue structures grown from stem cells that mimic key structural and functional features of real organs. They reproduce complex cellular interactions, architecture and biological behavior, making them more physiologically relevant than traditional 2D cell cultures. The primary purpose of organoids is to provide realistic biological models for disease research, drug discovery, toxicology testing and personalized medicine.

The organoids market consists of sales, by entities (organizations, sole traders, or partnerships), of organoids products that are miniaturized and simplified three-dimensional versions of organs produced in vitro. These structures are derived from stem cells or tissue cells and exhibit realistic microanatomy with self-renewal and differentiation capacities.

The global organoids market reached a value of nearly $690.06 million in 2024, having grown at a compound annual growth rate (CAGR) of 21.03% since 2019. The market is expected to grow from $690.06 million in 2024 to $1,605.46 million in 2029 at a rate of 18.40%. The market is then expected to grow at a CAGR of 17.71% from 2029 and reach $3,627.43 million in 2034.

Rise In Investments In Pharmaceutical And Biotechnology Companies

A Rise in investments in pharmaceutical and biotechnology companies contributed to the growth of the organoids market in the historic period. As funding surged within the biotech sector, organizations were able to allocate greater financial resources toward innovative platforms such as organoids, recognizing their potential to streamline drug development and reduce costly failures. Enhanced capital availability encouraged companies to expand laboratory capacities, acquire specialized stem cell technologies, and develop sophisticated organoid-based models for screening and validation. For instance, in September 2025, according to the Fierce Biotech, a US-based information services company, reported that the National Institutes of Health (NIH) is advancing its goal of minimizing animal use in drug testing by awarding $87 million in contracts to establish the Standardized Organoid Modeling (SOM) Cente. Therefore, Rise in investments in pharmaceutical and biotechnology companies drove the growth of the organoids market.

Focus On Vascularized And Functionally Mature Organoid Models

Companies operating in the organoids market are focusing on vascularized and functionally mature organoid models that better replicate human tissue architecture and physiological responses, enabling advancements in disease modeling, regenerative therapies, and drug testing applications. For instance, in June 2025, Cincinnati Children's Hospital Medical Center, a US-based hospital, engineered a liver organoid capable of forming its own organ-specific blood vessels, marking a significant advancement in tissue engineering. Using a multilayer gel technique, liver sinusoidal progenitor cells were guided to migrate, sprout, and integrate with surrounding liver cells to form functional sinusoid-like vasculature. These vascularized organoids also produced critical coagulation factors, including Factor VIII, and were able to correct bleeding in hemophilia-model mice. The approach helps overcome the long-standing limitation of organoids lacking internal vasculature, and may pave the way for transplantable liver tissue, enhanced disease models, and novel therapies for coagulation disorders.

The global organoids markets is concentrated, with large players operating in the market. The top 10 competitors in the market made up 33.53% of the total market in 2024.

Organoids Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by source, by applications and end-user.
  • Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework: - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by source, by application and end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard: - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments: - Information on recent developments in the market covered in the report
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid
  • 2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • 3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Corning Incorporated; Merck KGaA (Hubrecht Organoid Technology (HUB)); STEMCELL Technologies; Danaher Corporation (Cellesce Ltd)
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."

Table of Contents

1 Executive Summary

  • 1.1 Organoids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organoids Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Hepatic Organoid
    • 6.4.2 Colorectal Organoid
    • 6.4.3 Intestinal Organoid
    • 6.4.4 Other Organoid
  • 6.5 Market Segmentation By Source
    • 6.5.1 Pluripotent Stem Cells
    • 6.5.2 Organ-Specific Adult Stem Cells
  • 6.6 Market Segmentation By Application
    • 6.6.1 Developmental Biology
    • 6.6.2 Disease Pathology Of Infectious Disease
    • 6.6.3 Regenerative Medicine
    • 6.6.4 Drug Toxicity And Efficacy Testing
    • 6.6.5 Drug Discovery And Personalized Medicine
    • 6.6.6 Other Applications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals And Diagnostic Centers
    • 6.7.2 Biotechnology And Pharmaceutical Companies
    • 6.7.3 Other End-Users

7 Major Market Trends

  • 7.1 Focus On Vascularized And Functionally Mature Organoid Models
  • 7.2 Development Of Scalable, Long-Lasting Functional Organoid Models
  • 7.3 Innovation In Organoid Solutions For Biotherapeutic Research And To Expand Solutions
  • 7.4 Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
  • 7.5 Development Of Cardiac Organoids-Based Kits For Improved Cardiac Safety Testing

8 Organoids Growth Analysis And Strategic Analysis Framework

  • 8.1 Organoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B) Market
    • 8.2.1 Hospitals And Diagnostic Centers
    • 8.2.2 Biotechnology And Pharmaceutical Companies
    • 8.2.3 Other End-Users
  • 8.3 Organoids Market Growth Rate Analysis
  • 8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Organoids Total Addressable Market (TAM)
    • 8.7.1 TAM Comparison Analysis

9 Organoids Market Segmentation

  • 9.1 Global Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Organoids Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Organoids Market, Sub-Segmentation Of Hepatic Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Organoids Market, Sub-Segmentation Of Colorectal Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Organoids Market, Sub-Segmentation Of Intestinal Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Organoids Market, Sub-Segmentation Of Other Organoid, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Organoids Market, Regional and Country Analysis

  • 10.1 Organoids Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Organoids Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Organoids Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Investments
    • 11.33.11 Major Companies
  • 11.34 South Korea Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Organoids Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major Companies
  • 13.3 Eastern Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Organoids Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Organoids Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Organoids Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Organoids Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Organoids Market, Segmentation By Source, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Organoids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Thermo Fisher Scientific Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Corning Inc
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Merck KGaA (Hubrecht Organoid Technology (HUB))
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 STEMCELL Technologies Inc
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Danaher Corporation (Cellesce Ltd)
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Sartorius AG
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Charles River Laboratories International, Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Bio-Techne Corp.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Greiner Bio-One International GmbH
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 ACROBiosystems Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Crown Bioscience (OcellO B.V.)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 InSphero AG
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 ATCC (American Type Culture Collection)
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Axol Bioscience Ltd.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Newcells Biotech Ltd.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Pandorum Technologies Pvt. Ltd.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 3Dnamics Inc.
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 3D Biotek LLC
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 AMS Biotechnology (Europe) Limited
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 CelVivo ApS
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Merck Group Acquired HUB Organoids Holding B.V.
  • 22.2 Bruker Corporation Acquired Acquifer Imaging
  • 22.3 Molecular Devices Acquired Cellesce

23 Recent Developments In Organoids

  • 23.1 Standardized Organoid Platform Transforms AI-Driven Drug Testing
  • 23.2 Optical Graphene Stimulation Transforms Brain Organoid and Neuro-Biohybrid Research
  • 23.3 3D Organoid Platform Transforms Drug Screening for Precision Medicine

24 Opportunities And Strategies

  • 24.1 Organoids Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Organoids Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Organoids Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Organoids Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer